{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["HIF-1\u03b1", "IGF-1", "IGFBP-3", "alkaloids", "apoptosis", "colon cancer progression", "mutation", "oxidative stress"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37560308", "DateCompleted": {"Year": "2023", "Month": "08", "Day": "11"}, "DateRevised": {"Year": "2023", "Month": "08", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "25"}], "Language": ["eng"], "ELocationID": ["1201198", "10.3389/fendo.2023.1201198"], "Journal": {"ISSN": "1664-2392", "JournalIssue": {"Volume": "14", "PubDate": {"Year": "2023"}}, "Title": "Frontiers in endocrinology", "ISOAbbreviation": "Front Endocrinol (Lausanne)"}, "ArticleTitle": "Reactive oxygen species mediated apoptotic death of colon cancer cells: therapeutic potential of plant derived alkaloids.", "Pagination": {"StartPage": "1201198", "MedlinePgn": "1201198"}, "Abstract": {"AbstractText": ["Colorectal cancer (CRC) is one of the most deaths causing diseases worldwide. Several risk factors including hormones like insulin and insulin like growth factors (e.g., IGF-1) have been considered responsible for growth and progression of colon cancer. Though there is a huge advancement in the available screening as well as treatment techniques for CRC. There is no significant decrease in the mortality of cancer patients. Moreover, the current treatment approaches for CRC are associated with serious challenges like drug resistance and cancer re-growth. Given the severity of the disease, there is an urgent need for novel therapeutic agents with ideal characteristics. Several pieces of evidence suggested that natural products, specifically medicinal plants, and derived phytochemicals may serve as potential sources for novel drug discovery for various diseases including cancer. On the other hand, cancer cells like colon cancer require a high basal level of reactive oxygen species (ROS) to maintain its own cellular functions. However, excess production of intracellular ROS leads to cancer cell death <i>via</i> disturbing cellular redox homeostasis. Therefore, medicinal plants and derived phytocompounds that can enhance the intracellular ROS and induce apoptotic cell death in cancer cells <i>via</i> modulating various molecular targets including IGF-1 could be potential therapeutic agents. Alkaloids form a major class of such phytoconstituents that can play a key role in cancer prevention. Moreover, several preclinical and clinical studies have also evidenced that these compounds show potent anti-colon cancer effects and exhibit negligible toxicity towards the normal cells. Hence, the present evidence-based study aimed to provide an update on various alkaloids that have been reported to induce ROS-mediated apoptosis in colon cancer cells <i>via</i> targeting various cellular components including hormones and growth factors, which play a role in metastasis, angiogenesis, proliferation, and invasion. This study also provides an individual account on each such alkaloid that underwent clinical trials either alone or in combination with other clinical drugs. In addition, various classes of phytochemicals that induce ROS-mediated cell death in different kinds of cancers including colon cancer are discussed."], "CopyrightInformation": "Copyright \u00a9 2023 Nelson, Nuli, Mastanaiah, Saleem T. S., Birudala, Jamous, Alshargi, Kotha, Sudhan, Mani, Muthumanickam, Niranjan, Jain, Agrawal, Jadon, Mayasa, Jha, Kolesarova, Slama and Roychoudhury."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Raghavendra Institute of Pharmaceutical Education and Research, Anantapur, India."}], "LastName": "Nelson", "ForeName": "Vinod K", "Initials": "VK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Raghavendra Institute of Pharmaceutical Education and Research, Anantapur, India."}], "LastName": "Nuli", "ForeName": "Mohana Vamsi", "Initials": "MV"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Balaji College of Pharmacy, Anantapur, India."}], "LastName": "Mastanaiah", "ForeName": "Juturu", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Riyadh ELM University, Riyadh, Saudi Arabia."}], "LastName": "Saleem T S", "ForeName": "Mohamed", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy, Dr. M.G.R. Educational and Research Institute, Chennai, India."}], "LastName": "Birudala", "ForeName": "Geetha", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Vaccines and Bioprocessing Centre, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia."}], "LastName": "Jamous", "ForeName": "Yahya F", "Initials": "YF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Riyadh ELM University, Riyadh, Saudi Arabia."}], "LastName": "Alshargi", "ForeName": "Omar", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmaceutical Sciences, Dayananda Sagar University, Bengaluru, India."}], "LastName": "Kotha", "ForeName": "Kranthi Kumar", "Initials": "KK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Raghavendra Institute of Pharmaceutical Education and Research, Anantapur, India."}], "LastName": "Sudhan", "ForeName": "Hari Hara", "Initials": "HH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia."}], "LastName": "Mani", "ForeName": "Ravishankar Ram", "Initials": "RR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, ITM University, Gwalior, India."}], "LastName": "Muthumanickam", "ForeName": "Alagusundaram", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, ITM University, Gwalior, India."}], "LastName": "Niranjan", "ForeName": "Divya", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, ITM University, Gwalior, India."}], "LastName": "Jain", "ForeName": "Nem Kumar", "Initials": "NK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, ITM University, Gwalior, India."}], "LastName": "Agrawal", "ForeName": "Ankur", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Amity Institute of Pharmacy, Amity University, Gwalior, India."}], "LastName": "Jadon", "ForeName": "Arvind Singh", "Initials": "AS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "GITAM School of Pharmacy, GITAM University Hyderabad Campus, Rudraram, India."}], "LastName": "Mayasa", "ForeName": "Vinyas", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, India."}, {"Identifier": [], "Affiliation": "Department of Biotechnology, School of Applied & Life Sciences (SALS), Uttaranchal University, Dehradun, India."}, {"Identifier": [], "Affiliation": "School of Bioengineering & Biosciences, Lovely Professional University, Phagwara, India."}, {"Identifier": [], "Affiliation": "Department of Biotechnology Engineering and Food Technology, Chandigarh University, Mohali, India."}], "LastName": "Jha", "ForeName": "Niraj Kumar", "Initials": "NK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Biotechnology and Food Sciences, Slovak University of Agriculture in Nitra, Nitra, Slovakia."}], "LastName": "Kolesarova", "ForeName": "Adriana", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Animal Immunology and Biotechnology, Department of Animal Morphology, Physiology and Genetics, Faculty of AgriSciences, Mendel University in Brno, Brno, Czechia."}], "LastName": "Slama", "ForeName": "Petr", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Life Science and Bioinformatics, Assam University, Silchar, India."}], "LastName": "Roychoudhury", "ForeName": "Shubhadeep", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Endocrinol (Lausanne)", "NlmUniqueID": "101555782", "ISSNLinking": "1664-2392"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "67763-96-6", "NameOfSubstance": "Insulin-Like Growth Factor I"}, {"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Hormones"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": [], "DescriptorName": "Insulin-Like Growth Factor I"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Colonic Neoplasms"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Alkaloids"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Hormones"}], "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ma X, Yu H. Global burden of cancer. Yale J Biol Med (2006) 79(3-4):85\u201394.", "ArticleIdList": ["PMC1994799", "17940618"]}, {"Citation": "Nelson VK, Sahoo NK, Sahu M, Sudhan HH, Pullaiah CP, Muralikrishna KS. In vitro anticancer activity of eclipta alba whole plant extract on colon cancer cell HCT-116. BMC Complement Med Ther (2020) 20(1):355. doi:\u00a010.1186/s12906-020-03118-9", "ArticleIdList": ["10.1186/s12906-020-03118-9", "PMC7681951", "33225921"]}, {"Citation": "Abane R, Mezger V. Roles of heat shock factors in gametogenesis and development. FEBS J (2010) 277(20):4150\u201372. doi:\u00a010.1111/j.1742-4658.2010.07830.x", "ArticleIdList": ["10.1111/j.1742-4658.2010.07830.x", "20945531"]}, {"Citation": "Zaytseva Y. Lipid metabolism as a targetable metabolic vulnerability in colorectal cancer. Cancers (Basel) (2021) 13(2):1\u20135. doi:\u00a010.3390/cancers13020301", "ArticleIdList": ["10.3390/cancers13020301", "PMC7830794", "33467532"]}, {"Citation": "Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet (2019) 394(10207):1467\u201380. doi:\u00a010.1016/s0140-6736(19)32319-0", "ArticleIdList": ["10.1016/s0140-6736(19)32319-0", "31631858"]}, {"Citation": "Sawicki T, Ruszkowska M, Danielewicz A, Nied\u017awiedzka E, Ar\u0142ukowicz T, Przyby\u0142owicz KE. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers (Basel) (2021) 13(9):1\u201323. doi:\u00a010.3390/cancers13092025", "ArticleIdList": ["10.3390/cancers13092025", "PMC8122718", "33922197"]}, {"Citation": "Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol (2021) 14(10):101174. doi:\u00a010.1016/j.tranon.2021.101174", "ArticleIdList": ["10.1016/j.tranon.2021.101174", "PMC8273208", "34243011"]}, {"Citation": "White A, Ironmonger L, Steele RJC, Ormiston-Smith N, Crawford C, Seims A. A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK. BMC Cancer (2018) 18(1):906. doi:\u00a010.1186/s12885-018-4786-7", "ArticleIdList": ["10.1186/s12885-018-4786-7", "PMC6149054", "30236083"]}, {"Citation": "Brahmkhatri VP, Prasanna C, Atreya HS. Insulin-like growth factor system in cancer: novel targeted therapies. BioMed Res Int (2015) 2015:538019. doi:\u00a010.1155/2015/538019", "ArticleIdList": ["10.1155/2015/538019", "PMC4383470", "25866791"]}, {"Citation": "Chainy GBN, Sahoo DK. Hormones and oxidative stress: an overview. Free Radic Res (2020) 54(1):1\u201326. doi:\u00a010.1080/10715762.2019.1702656", "ArticleIdList": ["10.1080/10715762.2019.1702656", "31868060"]}, {"Citation": "Sahoo DK, Chainy GBN. Hormone-linked redox status and its modulation by antioxidants. Vitam Horm (2023) 121:197\u2013246. doi:\u00a010.1016/bs.vh.2022.10.007", "ArticleIdList": ["10.1016/bs.vh.2022.10.007", "36707135"]}, {"Citation": "Lukas M. Inflammatory bowel disease as a risk factor for colorectal cancer. Dig Dis (2010) 28(4-5):619\u201324. doi:\u00a010.1159/000320276", "ArticleIdList": ["10.1159/000320276", "21088413"]}, {"Citation": "Sahoo DK, Borcherding DC, Chandra L, Jergens AE, Atherly T, Bourgois-Mochel A, et al. . Differential transcriptomic profiles following stimulation with lipopolysaccharide in intestinal organoids from dogs with inflammatory bowel disease and intestinal mast cell tumor. Cancers (Basel) (2022) 14(14):1\u201359. doi:\u00a010.3390/cancers14143525", "ArticleIdList": ["10.3390/cancers14143525", "PMC9322748", "35884586"]}, {"Citation": "Gavrilas LI, Cruceriu D, Mocan A, Loghin F, Miere D, Balacescu O. Plant-derived bioactive compounds in colorectal cancer: insights from combined regimens with conventional chemotherapy to overcome drug-resistance. Biomedicines (2022) 10(8):1\u201314. doi:\u00a010.3390/biomedicines10081948", "ArticleIdList": ["10.3390/biomedicines10081948", "PMC9406120", "36009495"]}, {"Citation": "Braun MS, Seymour MT. Balancing the efficacy and toxicity of chemotherapy in colorectal cancer. Ther Adv Med Oncol (2011) 3(1):43\u201352. doi:\u00a010.1177/1758834010388342", "ArticleIdList": ["10.1177/1758834010388342", "PMC3126034", "21789155"]}, {"Citation": "Pardini B, Kumar R, Naccarati A, Novotny J, Prasad RB, Forsti A, et al. . 5-fluorouracil-based chemotherapy for colorectal cancer and MTHFR/MTRR genotypes. Br J Clin Pharmacol (2011) 72(1):162\u20133. doi:\u00a010.1111/j.1365-2125.2010.03892.x", "ArticleIdList": ["10.1111/j.1365-2125.2010.03892.x", "PMC3141199", "21204909"]}, {"Citation": "Dutta N, Ghosh S, Nelson VK, Sareng HR, Majumder C, Mandal SC, et al. . Andrographolide upregulates protein quality control mechanisms in cell and mouse through upregulation of mTORC1 function. Biochim Biophys Acta Gen Subj (2021) 1865(6):129885. doi:\u00a010.1016/j.bbagen.2021.129885", "ArticleIdList": ["10.1016/j.bbagen.2021.129885", "33639218"]}, {"Citation": "Ghosh S, Hazra J, Pal K, Nelson VK, Pal M. Prostate cancer: therapeutic prospect with herbal medicine. Curr Res Pharmacol Drug Discovery (2021) 2:100034. doi:\u00a010.1016/j.crphar.2021.100034", "ArticleIdList": ["10.1016/j.crphar.2021.100034", "PMC8663990", "34909665"]}, {"Citation": "Pullaiah CP, Nelson VK, Rayapu S, Nk G V, Kedam T. Exploring cardioprotective potential of esculetin against isoproterenol induced myocardial toxicity in rats: in vivo and in vitro evidence. BMC Pharmacol Toxicol (2021) 22(1):43. doi:\u00a010.1186/s40360-021-00510-0", "ArticleIdList": ["10.1186/s40360-021-00510-0", "PMC8281642", "34266475"]}, {"Citation": "Dutta N, Pemmaraju DB, Ghosh S, Ali A, Mondal A, Majumder C, et al. . Alkaloid-rich fraction of ervatamia coronaria sensitizes colorectal cancer through modulating AMPK and mTOR signalling pathways. J Ethnopharmacol (2022) 283:114666. doi:\u00a010.1016/j.jep.2021.114666", "ArticleIdList": ["10.1016/j.jep.2021.114666", "34592338"]}, {"Citation": "Nelson VK, Paul S, Roychoudhury S, Oyeyemi IT, Mandal SC, Kumar N, et al. . Heat shock factors in protein quality control and spermatogenesis. Adv Exp Med Biol (2022) 1391:181\u201399. doi:\u00a010.1007/978-3-031-12966-7_11", "ArticleIdList": ["10.1007/978-3-031-12966-7_11", "36472823"]}, {"Citation": "Nelson VK, Pullaiah CP, Saleem Ts M, Roychoudhury S, Chinnappan S, Vishnusai B, et al. . Natural products as the modulators of oxidative stress: an herbal approach in the management of prostate cancer. Adv Exp Med Biol (2022) 1391:161\u201379. doi:\u00a010.1007/978-3-031-12966-7_10", "ArticleIdList": ["10.1007/978-3-031-12966-7_10", "36472822"]}, {"Citation": "De S, Paul S, Manna A, Majumder C, Pal K, Casarcia N, et al. . Phenolic phytochemicals for prevention and treatment of colorectal cancer: a critical evaluation of In vivo studies. Cancers (Basel) (2023) 15(3):1\u201366. doi:\u00a010.3390/cancers15030993", "ArticleIdList": ["10.3390/cancers15030993", "PMC9913554", "36765950"]}, {"Citation": "Badavenkatappa Gari S, Nelson VK, Peraman R. Tinospora sinensis (Lour.) merr alkaloid rich extract induces colon cancer cell death via ROS mediated, mTOR dependent apoptosis pathway: \u201can in-vitro study\u201d. BMC Complement Med Ther (2023) 23(1):33. doi:\u00a010.1186/s12906-023-03849-5", "ArticleIdList": ["10.1186/s12906-023-03849-5", "PMC9896699", "36737760"]}, {"Citation": "Nelson VK, Ali A, Dutta N, Ghosh S, Jana M, Ganguli A, et al. . Azadiradione ameliorates polyglutamine expansion disease in drosophila by potentiating DNA binding activity of heat shock factor 1. Oncotarget (2016) 7(48):78281\u201396. doi:\u00a010.18632/oncotarget.12930", "ArticleIdList": ["10.18632/oncotarget.12930", "PMC5346638", "27835876"]}, {"Citation": "Liou GY, Storz P. Reactive oxygen species in cancer. Free Radic Res (2010) 44(5):479\u201396. doi:\u00a010.3109/10715761003667554", "ArticleIdList": ["10.3109/10715761003667554", "PMC3880197", "20370557"]}, {"Citation": "Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discovery (2009) 8(7):579\u201391. doi:\u00a010.1038/nrd2803", "ArticleIdList": ["10.1038/nrd2803", "19478820"]}, {"Citation": "Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discovery (2013) 12(12):931\u201347. doi:\u00a010.1038/nrd4002", "ArticleIdList": ["10.1038/nrd4002", "24287781"]}, {"Citation": "NavaneethaKrishnan S, Rosales JL, Lee KY. Targeting Cdk5 for killing of breast cancer cells via perturbation of redox homeostasis. Oncoscience (2018) 5(5-6):152\u20134. doi:\u00a010.18632/oncoscience.431", "ArticleIdList": ["10.18632/oncoscience.431", "PMC6049304", "30035173"]}, {"Citation": "Shimada Y, Yoshino M, Wakui A, Nakao I, Futatsuki K, Sakata Y, et al. . Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 gastrointestinal cancer study group. J Clin Oncol (1993) 11(5):909\u201313. doi:\u00a010.1200/jco.1993.11.5.909", "ArticleIdList": ["10.1200/jco.1993.11.5.909", "8487053"]}, {"Citation": "Kapa\u0142a A, Szlendak M, Motacka E. The anti-cancer activity of lycopene: a systematic review of human and animal studies. Nutrients (2022) 14(23):1\u201344. doi:\u00a010.3390/nu14235152", "ArticleIdList": ["10.3390/nu14235152", "PMC9741066", "36501182"]}, {"Citation": "Farsad-Naeimi A, Alizadeh M, Esfahani A, Darvish Aminabad E. Effect of fisetin supplementation on inflammatory factors and matrix metalloproteinase enzymes in colorectal cancer patients. Food Funct (2018) 9(4):2025\u201331. doi:\u00a010.1039/c7fo01898c", "ArticleIdList": ["10.1039/c7fo01898c", "29541713"]}, {"Citation": "Jiang X, Jiang Z, Jiang M, Sun Y. Berberine as a potential agent for the treatment of colorectal cancer. Front Med (Lausanne) (2022) 9:886996. doi:\u00a010.3389/fmed.2022.886996", "ArticleIdList": ["10.3389/fmed.2022.886996", "PMC9096113", "35572960"]}, {"Citation": "Aggarwal V, Tuli HS, Varol A, Thakral F, Yerer MB, Sak K, et al. . Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomolecules (2019) 9(11):1\u201326. doi:\u00a010.3390/biom9110735", "ArticleIdList": ["10.3390/biom9110735", "PMC6920770", "31766246"]}, {"Citation": "Sahoo DK, Allenspach K, Mochel JP, Parker V, Rudinsky AJ, Winston JA, et al. . Synbiotic-IgY therapy modulates the mucosal microbiome and inflammatory indices in dogs with chronic inflammatory enteropathy: a randomized, double-blind, placebo-controlled study. Vet Sci (2022) 10(1):1\u201318. doi:\u00a010.3390/vetsci10010025", "ArticleIdList": ["10.3390/vetsci10010025", "PMC9867299", "36669027"]}, {"Citation": "Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y, Hu LL. ERK/MAPK signalling pathway and tumorigenesis. Exp Ther Med (2020) 19(3):1997\u20132007. doi:\u00a010.3892/etm.2020.8454", "ArticleIdList": ["10.3892/etm.2020.8454", "PMC7027163", "32104259"]}, {"Citation": "Zhang Y, Gan B, Liu D. & paik J FoxO family members in cancer. Cancer Biol Ther (2011) 12:4. doi:\u00a010.4161/cbt.12.4.15954", "ArticleIdList": ["10.4161/cbt.12.4.15954", "21613825"]}, {"Citation": "Dai L, Zhuang L, Zhang B, Wang F, Chen X, Xia C, et al. . DAG/PKC\u03b4 and IP3/Ca\u00b2\u207a/CaMK II\u03b2 operate in parallel to each other in PLC\u03b31-driven cell proliferation and migration of human gastric adenocarcinoma cells, through Akt/mTOR/S6 pathway. Int J Mol Sci (2015) 16(12):28510\u201322. doi:\u00a010.3390/ijms161226116", "ArticleIdList": ["10.3390/ijms161226116", "PMC4691063", "26633375"]}, {"Citation": "Hwang AB, Lee SJ. Regulation of life span by mitochondrial respiration: the HIF-1 and ROS connection. Aging (2011), 304\u201310.", "ArticleIdList": ["PMC3091523", "21389351"]}, {"Citation": "Guba M, Seeliger H, Kleespies A, Jauch KW, Bruns C. Vascular endothelial growth factor in colorectal cancer. Int J Colorectal Dis (2004) 19(6):510\u20137. doi:\u00a010.1007/s00384-003-0576-y", "ArticleIdList": ["10.1007/s00384-003-0576-y", "14999511"]}, {"Citation": "Lee YJ, Karl DL, Maduekwe UN, Rothrock C, Ryeom S, D'Amore PA, et al. . Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environment. Cancer Res (2010) 70(21):8357\u201367. doi:\u00a010.1158/0008-5472.CAN-10-1138", "ArticleIdList": ["10.1158/0008-5472.CAN-10-1138", "PMC2970713", "20978198"]}, {"Citation": "Lan T, Chen L, Wei X. Inflammatory Cytokines in cancer: comprehensive understanding and clinical progress in gene therapy. Cells (2021) 10(1):100. doi: 10.3390/cells10010100", "ArticleIdList": ["10.3390/cells10010100", "PMC7827947", "33429846"]}, {"Citation": "NavaneethaKrishnan S, Rosales JL, Lee KY. ROS-mediated cancer cell killing through dietary phytochemicals. Oxid Med Cell Longev (2019) 2019:9051542. doi:\u00a010.1155/2019/9051542", "ArticleIdList": ["10.1155/2019/9051542", "PMC6536988", "31217841"]}, {"Citation": "Sreevalsan S, Safe S. REACTIVE OXYGEN SPECIES AND COLORECTAL CANCER. Curr Colorectal Cancer Rep (2013) 9(4):350\u20137. doi:\u00a010.1007/s11888-013-0190-5", "ArticleIdList": ["10.1007/s11888-013-0190-5", "PMC4288935", "25584043"]}, {"Citation": "Ahmed K, Zaidi SF, Cui ZG, Zhou D, Saeed SA, Inadera H. Potential proapoptotic phytochemical agents for the treatment and prevention of colorectal cancer. Oncol Lett (2019) 18(1):487\u201398. doi:\u00a010.3892/ol.2019.10349", "ArticleIdList": ["10.3892/ol.2019.10349", "PMC6540497", "31289520"]}, {"Citation": "Hill MM, Adrain C, Duriez PJ, Creagh EM, Martin SJ. Analysis of the composition, assembly kinetics and activity of native apaf-1 apoptosomes. EMBO J (2004) 23(10):2134\u201345. doi:\u00a010.1038/sj.emboj.7600210", "ArticleIdList": ["10.1038/sj.emboj.7600210", "PMC424369", "15103327"]}, {"Citation": "Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ (2006) 13(9):1423\u201333. doi:\u00a010.1038/sj.cdd.4401950", "ArticleIdList": ["10.1038/sj.cdd.4401950", "16676004"]}, {"Citation": "Silke J, Meier P. Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation. Cold Spring Harb Perspect Biol (2013) 5(2). doi:\u00a010.1101/cshperspect.a008730", "ArticleIdList": ["10.1101/cshperspect.a008730", "PMC3552501", "23378585"]}, {"Citation": "Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol (2007) 35(4):495\u2013516. doi:\u00a010.1080/01926230701320337", "ArticleIdList": ["10.1080/01926230701320337", "PMC2117903", "17562483"]}, {"Citation": "Bruckheimer EM, Cho SH, Sarkiss M, Herrmann J, McDonnell TJ. The bcl-2 gene family and apoptosis. Adv Biochem Eng Biotechnol (1998) 62:75\u2013105. doi:\u00a010.1007/BFb0102306", "ArticleIdList": ["10.1007/BFb0102306", "9755641"]}, {"Citation": "Hardwick JM, Soane L. Multiple functions of BCL-2 family proteins. Cold Spring Harb Perspect Biol (2013) 5(2). doi:\u00a010.1101/cshperspect.a008722", "ArticleIdList": ["10.1101/cshperspect.a008722", "PMC3552500", "23378584"]}, {"Citation": "Hempel N, Trebak M. Crosstalk between calcium and reactive oxygen species signaling in cancer. Cell Calcium (2017) 63:70\u201396. doi:\u00a010.1016/j.ceca.2017.01.007", "ArticleIdList": ["10.1016/j.ceca.2017.01.007", "PMC5466514", "28143649"]}, {"Citation": "Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta (2016) 1863(12):2977\u201392. doi: 1016/j.bbamcr.2016.09.012", "ArticleIdList": ["27646922"]}, {"Citation": "Park DR, Thomsen AR, Frevert CW, Pham U, Skerrett SJ, Kiener PA, et al. . Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J Immunol (2003) 170(12):6209\u201316. doi:\u00a010.4049/jimmunol.170.12.6209", "ArticleIdList": ["10.4049/jimmunol.170.12.6209", "12794152"]}, {"Citation": "Volpe E, Sambucci M, Battistini L, Borsellino G. Fas-fas ligand: checkpoint of T cell functions in multiple sclerosis. Front Immunol (2016) 7:382. doi:\u00a010.3389/fimmu.2016.00382", "ArticleIdList": ["10.3389/fimmu.2016.00382", "PMC5037862", "27729910"]}, {"Citation": "Pobezinskaya YL, Liu Z. The role of TRADD in death receptor signaling. Cell Cycle (2012) 11(5):871\u20136. doi:\u00a010.4161/cc.11.5.19300", "ArticleIdList": ["10.4161/cc.11.5.19300", "PMC3679287", "22333735"]}, {"Citation": "Huang YT, Liu CH, Yang YC, Aneja R, Wen SY, Huang CY, et al. . ROS- and HIF1\u03b1-dependent IGFBP3 upregulation blocks IGF1 survival signaling and thereby mediates high-glucose-induced cardiomyocyte apoptosis. J Cell Physiol (2019) 234(8):13557\u201370. doi:\u00a010.1002/jcp.28034", "ArticleIdList": ["10.1002/jcp.28034", "30659610"]}, {"Citation": "Akhtar R, Chandel S, Sarotra P, Medhi B. Current status of pharmacological treatment of colorectal cancer. World J Gastrointest Oncol (2014) 6(6):177\u201383. doi:\u00a010.4251/wjgo.v6.i6.177", "ArticleIdList": ["10.4251/wjgo.v6.i6.177", "PMC4058725", "24936228"]}, {"Citation": "Cassidy J, Misset JL. Oxaliplatin-related side effects: characteristics and management. Semin Oncol (2002) 29(5 Suppl 15):11\u201320. doi:\u00a010.1053/sonc.2002.35524", "ArticleIdList": ["10.1053/sonc.2002.35524", "12422304"]}, {"Citation": "Reynolds NA, Wagstaff AJ. Cetuximab: in the treatment of metastatic colorectal cancer. Drugs (2004) 64(1):109\u201318. doi:\u00a010.2165/00003495-200464010-00007", "ArticleIdList": ["10.2165/00003495-200464010-00007", "14723561"]}, {"Citation": "Willems E, Gerne L, George C, D\u2019Hondt M. Adverse effects of bevacizumab in metastatic colorectal cancer: a case report and literature review. Acta Gastroenterol Belg (2019) 82(2):322\u20135.", "ArticleIdList": ["31314196"]}, {"Citation": "Battaglin F, Puccini A, Ahcene Djaballah S, Lenz HJ. The impact of panitumumab treatment on survival and quality of life in patients with RAS wild-type metastatic colorectal cancer. Cancer Manag Res (2019) 11:5911\u201324. doi:\u00a010.2147/cmar.S186042", "ArticleIdList": ["10.2147/cmar.S186042", "PMC6607986", "31388315"]}, {"Citation": "Hirsch BR, Zafar SY. Capecitabine in the management of colorectal cancer. Cancer Manag Res (2011) 3:79\u201389. doi:\u00a010.2147/cmr.S11250", "ArticleIdList": ["10.2147/cmr.S11250", "PMC3097797", "21629830"]}, {"Citation": "Van der Jeught K, Xu HC, Li YJ, Lu XB, Ji G. Drug resistance and new therapies in colorectal cancer. World J Gastroenterol (2018) 24(34):3834\u201348. doi:\u00a010.3748/wjg.v24.i34.3834", "ArticleIdList": ["10.3748/wjg.v24.i34.3834", "PMC6141340", "30228778"]}, {"Citation": "Hasegawa K, Saiura A, Takayama T, Miyagawa S, Yamamoto J, Ijichi M, et al. . Adjuvant oral uracil-tegafur with leucovorin for colorectal cancer liver metastases: a randomized controlled trial. PloS One (2016) 11(9):e0162400. doi:\u00a010.1371/journal.pone.0162400", "ArticleIdList": ["10.1371/journal.pone.0162400", "PMC5010179", "27588959"]}, {"Citation": "Hata T, Hagihara K, Tsutsui A, Akamatsu H, Ohue M, Shingai T, et al. . Administration method of adjuvant tegafur-uracil and leucovorin calcium in patients with resected colorectal cancer: a phase III study. Oncologist (2021) 26(5):e735\u201341. doi:\u00a010.1002/onco.13724", "ArticleIdList": ["10.1002/onco.13724", "PMC8100551", "33604941"]}, {"Citation": "Singh V, Sheikh A, Abourehab MAS, Kesharwani P. Dostarlimab as a miracle drug: rising hope against cancer treatment. Biosensors (Basel) (2022) 12(8):1\u201314. doi:\u00a010.3390/bios12080617", "ArticleIdList": ["10.3390/bios12080617", "PMC9406030", "36005013"]}, {"Citation": "Xie YH, Chen YX, Fang JY. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther (2020) 5(1):22. doi:\u00a010.1038/s41392-020-0116-z", "ArticleIdList": ["10.1038/s41392-020-0116-z", "PMC7082344", "32296018"]}, {"Citation": "Rotte A. Combination of CTLA-4 and PD-1 blockers for treatment of cancer. J Exp Clin Cancer Res (2019) 38(1):255. doi:\u00a010.1186/s13046-019-1259-z", "ArticleIdList": ["10.1186/s13046-019-1259-z", "PMC6567914", "31196207"]}, {"Citation": "Savoia P, Astrua C, Fava P. Ipilimumab (Anti-Ctla-4 mab) in the treatment of metastatic melanoma: effectiveness and toxicity management. Hum Vaccin Immunother (2016) 12(5):1092\u2013101. doi:\u00a010.1080/21645515.2015.1129478", "ArticleIdList": ["10.1080/21645515.2015.1129478", "PMC4963052", "26889818"]}, {"Citation": "Kooshkaki O, Derakhshani A, Hosseinkhani N, Torabi M, Safaei S, Brunetti O, et al. . Combination of ipilimumab and nivolumab in cancers: from clinical practice to ongoing clinical trials. Int J Mol Sci (2020) 21(12):1\u201328. doi:\u00a010.3390/ijms21124427", "ArticleIdList": ["10.3390/ijms21124427", "PMC7352976", "32580338"]}, {"Citation": "Wookey V, Grothey A. Update on the role of pembrolizumab in patients with unresectable or metastatic colorectal cancer. Therap Adv Gastroenterol (2021) 14:17562848211024460. doi:\u00a010.1177/17562848211024460", "ArticleIdList": ["10.1177/17562848211024460", "PMC8246487", "34262612"]}, {"Citation": "Berg D. Managing the side effects of chemotherapy for colorectal cancer. Semin Oncol (1998) 25(5 Suppl 11):53\u20139.", "ArticleIdList": ["9786317"]}, {"Citation": "Golshani G, Zhang Y. Advances in immunotherapy for colorectal cancer: a review. Therap Adv Gastroenterol (2020) 13:1756284820917527. doi:\u00a010.1177/1756284820917527", "ArticleIdList": ["10.1177/1756284820917527", "PMC7268115", "32536977"]}, {"Citation": "Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin (2021) 71(3):209\u201349. doi:\u00a010.3322/caac.21660", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Hashem S, Ali TA, Akhtar S, Nisar S, Sageena G, Ali S, et al. . Targeting cancer signaling pathways by natural products: exploring promising anti-cancer agents. BioMed Pharmacother (2022) 150:113054. doi:\u00a010.1016/j.biopha.2022.113054", "ArticleIdList": ["10.1016/j.biopha.2022.113054", "35658225"]}, {"Citation": "Choudhari AS, Mandave PC, Deshpande M, Ranjekar P, Prakash O. Phytochemicals in cancer treatment: from preclinical studies to clinical practice. Front Pharmacol (2019) 10:1614. doi:\u00a010.3389/fphar.2019.01614", "ArticleIdList": ["10.3389/fphar.2019.01614", "PMC7025531", "32116665"]}, {"Citation": "Rahman MA, Hannan MA, Dash R, Rahman MH, Islam R, Uddin MJ, et al. . Phytochemicals as a complement to cancer chemotherapy: pharmacological modulation of the autophagy-apoptosis pathway. Front Pharmacol (2021) 12:639628. doi:\u00a010.3389/fphar.2021.639628", "ArticleIdList": ["10.3389/fphar.2021.639628", "PMC8138161", "34025409"]}, {"Citation": "Greenwell M, Rahman PK. Medicinal plants: their use in anticancer treatment. Int J Pharm Sci Res (2015) 6(10):4103\u201312. doi:\u00a010.13040/ijpsr.0975-8232.6(10).4103-12", "ArticleIdList": ["10.13040/ijpsr.0975-8232.6(10).4103-12", "PMC4650206", "26594645"]}, {"Citation": "Seca AML, Pinto DCGA. Biological potential and medical use of secondary metabolites. Medicines (Basel) (2019) 6(2):1\u20136. doi:\u00a010.3390/medicines6020066", "ArticleIdList": ["10.3390/medicines6020066", "PMC6632032", "31212776"]}, {"Citation": "Dhyani P, Quispe C, Sharma E, Bahukhandi A, Sati P, Attri DC, et al. . Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine. Cancer Cell Int (2022) 22(1):206. doi:\u00a010.1186/s12935-022-02624-9", "ArticleIdList": ["10.1186/s12935-022-02624-9", "PMC9161525", "35655306"]}, {"Citation": "Huang M, Lu JJ, Ding J. Natural products in cancer therapy: past, present and future. Nat Prod Bioprospect (2021) 11(1):5\u201313. doi:\u00a010.1007/s13659-020-00293-7", "ArticleIdList": ["10.1007/s13659-020-00293-7", "PMC7933288", "33389713"]}, {"Citation": "Xu Y, Fang F, Miriyala S, Crooks PA, Oberley TD, Chaiswing L, et al. . KEAP1 is a redox sensitive target that arbitrates the opposing radiosensitive effects of parthenolide in normal and cancer cells. Cancer Res (2013) 73(14):4406\u201317. doi:\u00a010.1158/0008-5472.Can-12-4297", "ArticleIdList": ["10.1158/0008-5472.Can-12-4297", "PMC3715565", "23674500"]}, {"Citation": "Khan H, Alam W, Alsharif KF, Aschner M, Pervez S, Saso L. Alkaloids and colon cancer: molecular mechanisms and therapeutic implications for cell cycle arrest. Molecules (2022) 27(3):1\u201326. doi:\u00a010.3390/molecules27030920", "ArticleIdList": ["10.3390/molecules27030920", "PMC8838632", "35164185"]}, {"Citation": "Heinrich M, Mah J, Amirkia V. Alkaloids used as medicines: structural phytochemistry meets biodiversity-an update and forward look. Molecules (2021) 26(7):1\u201326. doi:\u00a010.3390/molecules26071836", "ArticleIdList": ["10.3390/molecules26071836", "PMC8036335", "33805869"]}, {"Citation": "Gong X, Chen Z, Han Q, Chen C, Jing L, Liu Y, et al. . Sanguinarine triggers intrinsic apoptosis to suppress colorectal cancer growth through disassociation between STRAP and MELK. BMC Cancer (2018) 18(1):578. doi:\u00a010.1186/s12885-018-4463-x", "ArticleIdList": ["10.1186/s12885-018-4463-x", "PMC5963096", "29783958"]}, {"Citation": "Matkar SS, Wrischnik LA, Hellmann-Blumberg U. Sanguinarine causes DNA damage and p53-independent cell death in human colon cancer cell lines. Chem Biol Interact (2008) 172(1):63\u201371. doi:\u00a010.1016/j.cbi.2007.12.006", "ArticleIdList": ["10.1016/j.cbi.2007.12.006", "18243168"]}, {"Citation": "Yin HQ, Kim YH, Moon CK, Lee BH. Reactive oxygen species-mediated induction of apoptosis by a plant alkaloid 6-methoxydihydrosanguinarine in HepG2 cells. Biochem Pharmacol (2005) 70(2):242\u20138. doi:\u00a010.1016/j.bcp.2005.04.020", "ArticleIdList": ["10.1016/j.bcp.2005.04.020", "15904897"]}, {"Citation": "Dai W, Mu L, Cui Y, Li Y, Chen P, Xie H, et al. . Berberine promotes apoptosis of colorectal cancer via regulation of the long non-coding RNA (lncRNA) cancer susceptibility candidate 2 (CASC2)/AU-binding factor 1 (AUF1)/B-cell CLL/Lymphoma 2 (Bcl-2) axis. Med Sci Monit (2019) 25:730\u20138. doi:\u00a010.12659/msm.912082", "ArticleIdList": ["10.12659/msm.912082", "PMC6357823", "30681073"]}, {"Citation": "Wang L, Liu L, Shi Y, Cao H, Chaturvedi R, Calcutt MW, et al. . Berberine induces caspase-independent cell death in colon tumor cells through activation of apoptosis-inducing factor. PloS One (2012) 7(5):e36418. doi:\u00a010.1371/journal.pone.0036418", "ArticleIdList": ["10.1371/journal.pone.0036418", "PMC3344856", "22574158"]}, {"Citation": "Park JJ, Seo SM, Kim EJ, Lee YJ, Ko YG, Ha J, et al. . Berberine inhibits human colon cancer cell migration via AMP-activated protein kinase-mediated downregulation of integrin \u03b21 signaling. Biochem Biophys Res Commun (2012) 426(4):461\u20137. doi:\u00a010.1016/j.bbrc.2012.08.091", "ArticleIdList": ["10.1016/j.bbrc.2012.08.091", "22943849"]}, {"Citation": "Hsu WH, Hsieh YS, Kuo HC, Teng CY, Huang HI, Wang CJ, et al. . Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL. Arch Toxicol (2007) 81(10):719\u201328. doi:\u00a010.1007/s00204-006-0169-y", "ArticleIdList": ["10.1007/s00204-006-0169-y", "17673978"]}, {"Citation": "Li W, Hua B, Saud SM, Lin H, Hou W, Matter MS, et al. . Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice. Mol Carcinog (2015) 54(10):1096\u2013109. doi:\u00a010.1002/mc.22179", "ArticleIdList": ["10.1002/mc.22179", "PMC4504840", "24838344"]}, {"Citation": "Liu X, Ji Q, Ye N, Sui H, Zhou L, Zhu H, et al. . Berberine inhibits invasion and metastasis of colorectal cancer cells via COX-2/PGE2 mediated JAK2/STAT3 signaling pathway. PloS One (2015) 10(5):e0123478. doi:\u00a010.1371/journal.pone.0123478", "ArticleIdList": ["10.1371/journal.pone.0123478", "PMC4425560", "25954974"]}, {"Citation": "Wu K, Yang Q, Mu Y, Zhou L, Liu Y, Zhou Q, et al. . Berberine inhibits the proliferation of colon cancer cells by inactivating wnt/\u03b2-catenin signaling. Int J Oncol (2012) 41(1):292\u20138. doi:\u00a010.3892/ijo.2012.1423", "ArticleIdList": ["10.3892/ijo.2012.1423", "22469784"]}, {"Citation": "Li D, Zhang Y, Liu K, Zhao Y, Xu B, Xu L, et al. . Berberine inhibits colitis-associated tumorigenesis via suppressing inflammatory responses and the consequent EGFR signaling-involved tumor cell growth. Lab Invest (2017) 97(11):1343\u201353. doi:\u00a010.1038/labinvest.2017.71", "ArticleIdList": ["10.1038/labinvest.2017.71", "28759012"]}, {"Citation": "Samadi P, Sarvarian P, Gholipour E, Asenjan KS, Aghebati-Maleki L, Motavalli R, et al. . Berberine: a novel therapeutic strategy for cancer. IUBMB Life (2020) 72(10):2065\u201379. doi:\u00a010.1002/iub.2350", "ArticleIdList": ["10.1002/iub.2350", "32735398"]}, {"Citation": "Zhao Y, Roy S, Wang C, Goel A. A combined treatment with berberine and andrographis exhibits enhanced anti-cancer activity through suppression of DNA replication in colorectal cancer. Pharm (Basel) (2022) 15(3):1\u201317. doi:\u00a010.3390/ph15030262", "ArticleIdList": ["10.3390/ph15030262", "PMC8953248", "35337060"]}, {"Citation": "Guan X, Zheng X, Vong CT, Zhao J, Xiao J, Wang Y, et al. . Combined effects of berberine and evodiamine on colorectal cancer cells and cardiomyocytes in vitro . Eur J Pharmacol (2020) 875:173031. doi:\u00a010.1016/j.ejphar.2020.173031", "ArticleIdList": ["10.1016/j.ejphar.2020.173031", "32109457"]}, {"Citation": "Rattanawong A, Payon V, Limpanasittikul W, Boonkrai C, Mutirangura A, Wonganan P. Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1. Oncol Rep (2018) 39(1):227\u201338. doi:\u00a010.3892/or.2017.6084", "ArticleIdList": ["10.3892/or.2017.6084", "29138869"]}, {"Citation": "Han B, Jiang P, Li Z, Yu Y, Huang T, Ye X, et al. . Coptisine-induced apoptosis in human colon cancer cells (HCT-116) is mediated by PI3K/Akt and mitochondrial-associated apoptotic pathway. Phytomedicine (2018) 48:152\u201360. doi:\u00a010.1016/j.phymed.2017.12.027", "ArticleIdList": ["10.1016/j.phymed.2017.12.027", "30195873"]}, {"Citation": "Huang T, Xiao Y, Yi L, Li L, Wang M, Tian C, et al. . Coptisine from rhizoma coptidis suppresses HCT-116 cells-related tumor growth in vitro and in vivo . Sci Rep (2017) 7:38524. doi:\u00a010.1038/srep38524", "ArticleIdList": ["10.1038/srep38524", "PMC5292956", "28165459"]}, {"Citation": "Cao Q, Hong S, Li Y, Chen H, Shen Y, Shao K, et al. . Coptisine suppresses tumor growth and progression by down-regulating MFG-E8 in colorectal cancer. RSC Adv (2018) 8(54):30937\u201345. doi:\u00a010.1039/c8ra05806g", "ArticleIdList": ["10.1039/c8ra05806g", "PMC9085504", "35548723"]}, {"Citation": "Manogaran P, Beeraka NM, Huang CY, Vijaya Padma V. Neferine and isoliensinine enhance \u2018intracellular uptake of cisplatin\u2019 and induce \u2018ROS-mediated apoptosis\u2019 in colorectal cancer cells - a comparative study. Food Chem Toxicol (2019) 132:110652. doi:\u00a010.1016/j.fct.2019.110652", "ArticleIdList": ["10.1016/j.fct.2019.110652", "31255669"]}, {"Citation": "Manogaran P, Somasundaram B, Viswanadha VP. Reversal of cisplatin resistance by neferine/isoliensinine and their combinatorial regimens with cisplatin-induced apoptosis in cisplatin-resistant colon cancer stem cells (CSCs). J Biochem Mol Toxicol (2022) 36(3):e22967. doi:\u00a010.1002/jbt.22967", "ArticleIdList": ["10.1002/jbt.22967", "34921482"]}, {"Citation": "Liu X, Zhang Y, Wu S, Xu M, Shen Y, Yu M, et al. . Palmatine induces G2/M phase arrest and mitochondrial-associated pathway apoptosis in colon cancer cells by targeting AURKA. Biochem Pharmacol (2020) 175:113933. doi:\u00a010.1016/j.bcp.2020.113933", "ArticleIdList": ["10.1016/j.bcp.2020.113933", "32224138"]}, {"Citation": "Meng LH, Zhang H, Hayward L, Takemura H, Shao RG, Pommier Y. Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-s-specific cyclin-dependent kinases and by inducing p53 and p21Cip1. Cancer Res (2004) 64(24):9086\u201392. doi:\u00a010.1158/0008-5472.Can-04-0313", "ArticleIdList": ["10.1158/0008-5472.Can-04-0313", "15604277"]}, {"Citation": "Qin R, Shen H, Cao Y, Fang Y, Li H, Chen Q, et al. . Tetrandrine induces mitochondria-mediated apoptosis in human gastric cancer BGC-823 cells. PloS One (2013) 8(10):e76486. doi:\u00a010.1371/journal.pone.0076486", "ArticleIdList": ["10.1371/journal.pone.0076486", "PMC3788110", "24098511"]}, {"Citation": "Li X, Zhen D, Lu X, Xu H, Shao Y, Xue Q, et al. . Enhanced cytotoxicity and activation of ROS-dependent c-jun NH2-terminal kinase and caspase-3 by low doses of tetrandrine-loaded nanoparticles in lovo cells\u2013a possible Trojan strategy against cancer. Eur J Pharm Biopharm (2010) 75(3):334\u201340. doi:\u00a010.1016/j.ejpb.2010.04.016", "ArticleIdList": ["10.1016/j.ejpb.2010.04.016", "20438840"]}, {"Citation": "Santos LS, Silva VR, Menezes LRA, Soares MBP, Costa EV, Bezerra DP. Xylopine induces oxidative stress and causes G(2)/M phase arrest, triggering caspase-mediated apoptosis by p53-independent pathway in HCT116 cells. Oxid Med Cell Longev (2017) 2017:7126872. doi:\u00a010.1155/2017/7126872", "ArticleIdList": ["10.1155/2017/7126872", "PMC5736936", "29362667"]}, {"Citation": "Lorence A, Medina-Bolivar F, Nessler CL. Camptothecin and 10-hydroxycamptothecin from camptotheca acuminata hairy roots. Plant Cell Rep (2004) 22(6):437\u201341. doi:\u00a010.1007/s00299-003-0708-4", "ArticleIdList": ["10.1007/s00299-003-0708-4", "13680137"]}, {"Citation": "Ha SW, Kim YJ, Kim W, Lee CS. Antitumor effects of camptothecin combined with conventional anticancer drugs on the cervical and uterine squamous cell carcinoma cell line SiHa. Korean J Physiol Pharmacol (2009) 13(2):115\u201321. doi:\u00a010.4196/kjpp.2009.13.2.115", "ArticleIdList": ["10.4196/kjpp.2009.13.2.115", "PMC2766704", "19885006"]}, {"Citation": "Park K, Abebe W, Fermin C, Reddy G, Habtemariam T, Chung J, et al. . Hypoxia inhibition of camptothecin-induced apoptosis by bax loss. Biologia (2012) 67:616\u201321. doi:\u00a010.2478/s11756-012-0037-6", "ArticleIdList": ["10.2478/s11756-012-0037-6"]}, {"Citation": "Liskova V, Kajsik M, Chovancova B, Roller L, Krizanova O. Camptothecin, triptolide, and apoptosis inducer kit have differential effects on mitochondria in colorectal carcinoma cells. FEBS Open Bio (2022) 12(5):913\u201324. doi:\u00a010.1002/2211-5463.13401", "ArticleIdList": ["10.1002/2211-5463.13401", "PMC9063445", "35318813"]}, {"Citation": "Wenzel U, Nickel A, Kuntz S, Daniel H. Ascorbic acid suppresses drug-induced apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions. Carcinogenesis (2004) 25(5):703\u201312. doi:\u00a010.1093/carcin/bgh079", "ArticleIdList": ["10.1093/carcin/bgh079", "14754875"]}, {"Citation": "Guo Z, Wang Z, Liang R, Tian H, Chen X, Chen M. Reactive oxygen species activated by mitochondria-specific camptothecin prodrug for enhanced chemotherapy. Bosn J Basic Med Sci (2022) 22(6):934\u201348. doi:\u00a010.17305/bjbms.2022.7194", "ArticleIdList": ["10.17305/bjbms.2022.7194", "PMC9589304", "35801419"]}, {"Citation": "Fujita K, Kubota Y, Ishida H, Sasaki Y. Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer. World J Gastroenterol (2015) 21(43):12234\u201348. doi:\u00a010.3748/wjg.v21.i43.12234", "ArticleIdList": ["10.3748/wjg.v21.i43.12234", "PMC4649109", "26604633"]}, {"Citation": "Britten CD, Hilsenbeck SG, Eckhardt SG, Marty J, Mangold G, MacDonald JR, et al. . Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model. Cancer Res (1999) 59(5):1049\u201353.", "ArticleIdList": ["10070962"]}, {"Citation": "Raymond E, Louvet C, Tournigand C, Coudray AM, Faivre S, De Gramont A, et al. . Pemetrexed disodium combined with oxaliplatin, SN38, or 5-fluorouracil, based on the quantitation of drug interactions in human HT29 colon cancer cells. Int J Oncol (2002) 21(2):361\u20137. doi: 10.3892/ijo.21.2.361", "ArticleIdList": ["10.3892/ijo.21.2.361", "12118332"]}, {"Citation": "Allegrini G, Goulette FA, Darnowski JW, Calabresi P. Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice. Cancer Chemother Pharmacol (2004) 53(3):261\u20136. doi:\u00a010.1007/s00280-003-0712-y", "ArticleIdList": ["10.1007/s00280-003-0712-y", "14658007"]}, {"Citation": "Di Bartolomeo M, Ciarlo A, Bertolini A, Barni S, Verusio C, Aitini E, et al. . Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-b regimen) as first-line treatment of patients with advanced colorectal cancer. an Italian trials of medical oncology phase II study. Eur J Cancer (2015) 51(4):473\u201381. doi:\u00a010.1016/j.ejca.2014.12.020", "ArticleIdList": ["10.1016/j.ejca.2014.12.020", "25637137"]}, {"Citation": "Cai Y, Deng R, Hu H, Zhang J, Ling J, Wu Z, et al. . [Analysis on safety and preliminary efficacy of dose-modified regimen of 5-fluorouracil plus oxaliplatin and irinotecan (FOLFOXIRI) in advanced colorectal cancer]. Zhonghua Wei Chang Wai Ke Za Zhi (2018) 21(9):1045\u201350.", "ArticleIdList": ["30269326"]}, {"Citation": "Reyes-Escogido Mde L, Gonzalez-Mondragon EG, Vazquez-Tzompantzi E. Chemical and pharmacological aspects of capsaicin. Molecules (2011) 16(2):1253\u201370. doi:\u00a010.3390/molecules16021253", "ArticleIdList": ["10.3390/molecules16021253", "PMC6259610", "21278678"]}, {"Citation": "Yang KM, Pyo JO, Kim GY, Yu R, Han IS, Ju SA, et al. . Capsaicin induces apoptosis by generating reactive oxygen species and disrupting mitochondrial transmembrane potential in human colon cancer cell lines. Cell Mol Biol Lett (2009) 14(3):497\u2013510. doi:\u00a010.2478/s11658-009-0016-2", "ArticleIdList": ["10.2478/s11658-009-0016-2", "PMC6275774", "19381455"]}, {"Citation": "Kim CS, Park WH, Park JY, Kang JH, Kim MO, Kawada T, et al. . Capsaicin, a spicy component of hot pepper, induces apoptosis by activation of the peroxisome proliferator-activated receptor gamma in HT-29 human colon cancer cells. J Med Food (2004) 7(3):267\u201373. doi:\u00a010.1089/jmf.2004.7.267", "ArticleIdList": ["10.1089/jmf.2004.7.267", "15383218"]}, {"Citation": "Kim YM, Hwang JT, Kwak DW, Lee YK, Park OJ. Involvement of AMPK signaling cascade in capsaicin-induced apoptosis of HT-29 colon cancer cells. Ann N Y Acad Sci (2007) 1095:496\u2013503. doi:\u00a010.1196/annals.1397.053", "ArticleIdList": ["10.1196/annals.1397.053", "17404062"]}, {"Citation": "Lu HF, Chen YL, Yang JS, Yang YY, Liu JY, Hsu SC, et al. . Antitumor activity of capsaicin on human colon cancer cells in vitro and colo 205 tumor xenografts in vivo . J Agric Food Chem (2010) 58(24):12999\u20133005. doi:\u00a010.1021/jf103335w", "ArticleIdList": ["10.1021/jf103335w", "21082859"]}, {"Citation": "Clark R, Lee J, Lee SH. Synergistic anticancer activity of capsaicin and 3,3\u2019-diindolylmethane in human colorectal cancer. J Agric Food Chem (2015) 63(17):4297\u2013304. doi:\u00a010.1021/jf506098s", "ArticleIdList": ["10.1021/jf506098s", "25876645"]}, {"Citation": "Kim MY, Trudel LJ, Wogan GN. Apoptosis induced by capsaicin and resveratrol in colon carcinoma cells requires nitric oxide production and caspase activation. Anticancer Res (2009) 29(10):3733\u201340.", "ArticleIdList": ["19846903"]}, {"Citation": "Waziri PM, Abdullah R, Yeap SK, Omar AR, Kassim NK, Malami I, et al. . Clausenidin induces caspase-dependent apoptosis in colon cancer. BMC Complement Altern Med (2016) 16:256. doi:\u00a010.1186/s12906-016-1247-1", "ArticleIdList": ["10.1186/s12906-016-1247-1", "PMC4966865", "27473055"]}, {"Citation": "Song N, Ma J, Hu W, Guo Y, Hui L, Aamer M, et al. . Lappaconitine hydrochloride inhibits proliferation and induces apoptosis in human colon cancer HCT-116 cells via mitochondrial and MAPK pathway. Acta Histochem (2021) 123(5):151736. doi:\u00a010.1016/j.acthis.2021.151736", "ArticleIdList": ["10.1016/j.acthis.2021.151736", "34058516"]}, {"Citation": "Yaffe PB, Power Coombs MR, Doucette CD, Walsh M, Hoskin DW. Piperine, an alkaloid from black pepper, inhibits growth of human colon cancer cells via G1 arrest and apoptosis triggered by endoplasmic reticulum stress. Mol Carcinog (2015) 54(10):1070\u201385. doi:\u00a010.1002/mc.22176", "ArticleIdList": ["10.1002/mc.22176", "24819444"]}, {"Citation": "DA Silva Machado F, Munari FM, Scariot FJ, Echeverrigaray S, Aguzzoli C, Pich CT, et al. . Piperlongumine induces apoptosis in colorectal cancer HCT 116 cells independent of bax, p21 and p53 status. Anticancer Res (2018) 38(11):6231\u20136. doi:\u00a010.21873/anticanres.12978", "ArticleIdList": ["10.21873/anticanres.12978", "30396942"]}, {"Citation": "Chen W, Lian W, Yuan Y, Li M. The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress. Cell Death Dis (2019) 10(8):600. doi:\u00a010.1038/s41419-019-1824-6", "ArticleIdList": ["10.1038/s41419-019-1824-6", "PMC6687721", "31395855"]}, {"Citation": "Kim GD. Harmine hydrochloride triggers G2/M cell cycle arrest and apoptosis in HCT116 cells through ERK and PI3K/AKT/mTOR signaling pathways. Prev Nutr Food Sci (2021) 26(4):445\u201352. doi:\u00a010.3746/pnf.2021.26.4.445", "ArticleIdList": ["10.3746/pnf.2021.26.4.445", "PMC8747958", "35047441"]}, {"Citation": "Liu J, Li Q, Liu Z, Lin L, Zhang X, Cao M, et al. . Harmine induces cell cycle arrest and mitochondrial pathway-mediated cellular apoptosis in SW620 cells via inhibition of the akt and ERK signaling pathways. Oncol Rep (2016) 35(6):3363\u201370. doi:\u00a010.3892/or.2016.4695", "ArticleIdList": ["10.3892/or.2016.4695", "27004568"]}, {"Citation": "Liang L, Wu J, Luo J, Wang L, Chen ZX, Han CL, et al. . Oxymatrine reverses 5-fluorouracil resistance by inhibition of colon cancer cell epithelial-mesenchymal transition and NF-\u03baB signaling in vitro . Oncol Lett (2020) 19(1):519\u201326. doi:\u00a010.3892/ol.2019.11090", "ArticleIdList": ["10.3892/ol.2019.11090", "PMC6924048", "31897166"]}, {"Citation": "Pan D, Zhang W, Zhang N, Xu Y, Chen Y, Peng J, et al. . Oxymatrine synergistically enhances doxorubicin anticancer effects in colorectal cancer. Front Pharmacol (2021) 12:673432. doi:\u00a010.3389/fphar.2021.673432", "ArticleIdList": ["10.3389/fphar.2021.673432", "PMC8297828", "34305593"]}, {"Citation": "Kumar A, Singh B, Sharma PR, Bharate SB, Saxena AK, Mondhe DM. A novel microtubule depolymerizing colchicine analogue triggers apoptosis and autophagy in HCT-116 colon cancer cells. Cell Biochem Funct (2016) 34(2):69\u201381. doi:\u00a010.1002/cbf.3166", "ArticleIdList": ["10.1002/cbf.3166", "26919061"]}, {"Citation": "Huang Z, Xu Y, Peng W. Colchicine induces apoptosis in HT\u221229 human colon cancer cells via the AKT and c-jun n-terminal kinase signaling pathways. Mol Med Rep (2015) 12(4):5939\u201344. doi:\u00a010.3892/mmr.2015.4222", "ArticleIdList": ["10.3892/mmr.2015.4222", "26299305"]}, {"Citation": "Seufferlein T, Ettrich TJ, Menzler S, Messmann H, Kleber G, Zipprich A, et al. . Green tea extract to prevent colorectal adenomas, results of a randomized, placebo-controlled clinical trial. Am J Gastroenterol (2022) 117(6):884\u201394. doi:\u00a010.14309/ajg.0000000000001706", "ArticleIdList": ["10.14309/ajg.0000000000001706", "35213393"]}, {"Citation": "Singh AP, Singh R, Verma SS, Rai V, Kaschula CH, Maiti P, et al. . Health benefits of resveratrol: evidence from clinical studies. Med Res Rev (2019) 39(5):1851\u201391. doi:\u00a010.1002/med.21565", "ArticleIdList": ["10.1002/med.21565", "30741437"]}, {"Citation": "Wu XY, Zhai J, Huan XK, Xu WW, Tian J, Farhood B. A systematic review of the therapeutic potential of resveratrol during colorectal cancer chemotherapy. Mini Rev Med Chem (2022) 23(10):1137\u201352. doi:\u00a010.2174/1389557522666220907145153", "ArticleIdList": ["10.2174/1389557522666220907145153", "36173048"]}, {"Citation": "Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, et al. . Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res (2004) 10(20):6847\u201354. doi:\u00a010.1158/1078-0432.Ccr-04-0744", "ArticleIdList": ["10.1158/1078-0432.Ccr-04-0744", "15501961"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "4", "Day": "6"}, {"Year": "2023", "Month": "6", "Day": "28"}, {"Year": "2023", "Month": "8", "Day": "11", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "8", "Day": "10", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "8", "Day": "10", "Hour": "4", "Minute": "26"}, {"Year": "2023", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["37560308", "PMC10408138", "10.3389/fendo.2023.1201198"]}}], "PubmedBookArticle": []}